Kathryn Guarini is Director of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 448 shares of REGN, which is worth approximately $302,753. The most recent transaction as insider was on Jan 02, 2025, when has been sold 166 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 448
58.87% 3M change
58.87% 12M change
Total Value Held $302,753

Kathryn Guarini Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2025
BUY
Grant, award, or other acquisition
-
166 Added 27.04%
448 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
-
42 Added 12.96%
282 Common Stock
Sep 08 2023
BUY
Grant, award, or other acquisition
-
240 Added 50.0%
240 Common Stock
KG

Kathryn Guarini

Director
Tarrytown, NY

Track Institutional and Insider Activities on REGN

Follow REGENERON PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REGN shares.

Notify only if

Insider Trading

Get notified when an Regeneron Pharmaceuticals, Inc. insider buys or sells REGN shares.

Notify only if

News

Receive news related to REGENERON PHARMACEUTICALS, INC.

Track Activities on REGN